A new CRISPR-based gene-editing therapy shows promise for treating severe high cholesterol by disabling the ANGPTL3 gene. Early trial results in 15 patients demonstrated significant reductions in LDL cholesterol and triglycerides, potentially offering a one-time, long-lasting solution for difficult-to-manage cases.source https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/new-gene-editing-therapy-may-lower-cholesterol-permanently-study-finds/articleshow/125191054.cms